HIV-1 latency in resting CD4+ T cells represents a major barrier to virus eradication in patients on highly active antiretroviral therapy (HAART). Eliminating the latent HIV-1 reservoir may require the reactivation of viral gene expression in latently infected cells. Most approaches for reactivating latent HIV-1 require nonspecific T cell activation, which has potential toxicity. To identify factors for reactivating latent HIV-1 without inducing global T cell activation, we performed a previously undescribed unbiased screen for genes that could activate transcription from the HIV-1 LTR in an NF- B-independent manner, and isolated an alternatively spliced form of the transcription factor Ets-1, VII-Ets-1. VII-Ets-1 activated HIV-1 transcript...
A major barrier to development of a cure for HIV-1 is the ability of the virus to establish latent i...
Highly active antiretroviral therapy (HAART) can reduce plasma HIV-1 levels in infected individuals ...
AbstractReplication-competent latent HIV-1 proviruses that persist in the genomes of a very small su...
To counter HIV latency, it is important to develop a better understanding of the full range of host ...
Background\ud Latent HIV-1 reservoirs are identified as one of the major challenges to achieve HIV-1...
The use of antiretroviral therapy in HIV type 1 (HIV-1)–infected patients does not lead to virus era...
Current antiretroviral therapy (ART) efficiently controls HIV-1 replication but fails to eradicate t...
BACKGROUND: Latent HIV-1 reservoirs are identified as one of the major challenges to achieve HIV-1 c...
The biomolecular mechanisms controlling latent HIV-1 infection, despite their importance for the dev...
Despite its clinical importance, the molecular biology of HIV-1 latency control is at best partially...
Human immunodeficiency virus (HIV) infection is currently incurable, due to the persistence of laten...
AbstractAntiretroviral therapy is unable to eliminate HIV infection in a small, long-lived populatio...
The mitochondrial antiviral signaling protein (MAVS) is involved in response to viral infection, and...
Aids has become the leading cause of death world-wide. Much research has been done on the causal age...
The main obstacle to cure HIV-1 is the latent reservoir. Antiretroviral therapy effectively controls...
A major barrier to development of a cure for HIV-1 is the ability of the virus to establish latent i...
Highly active antiretroviral therapy (HAART) can reduce plasma HIV-1 levels in infected individuals ...
AbstractReplication-competent latent HIV-1 proviruses that persist in the genomes of a very small su...
To counter HIV latency, it is important to develop a better understanding of the full range of host ...
Background\ud Latent HIV-1 reservoirs are identified as one of the major challenges to achieve HIV-1...
The use of antiretroviral therapy in HIV type 1 (HIV-1)–infected patients does not lead to virus era...
Current antiretroviral therapy (ART) efficiently controls HIV-1 replication but fails to eradicate t...
BACKGROUND: Latent HIV-1 reservoirs are identified as one of the major challenges to achieve HIV-1 c...
The biomolecular mechanisms controlling latent HIV-1 infection, despite their importance for the dev...
Despite its clinical importance, the molecular biology of HIV-1 latency control is at best partially...
Human immunodeficiency virus (HIV) infection is currently incurable, due to the persistence of laten...
AbstractAntiretroviral therapy is unable to eliminate HIV infection in a small, long-lived populatio...
The mitochondrial antiviral signaling protein (MAVS) is involved in response to viral infection, and...
Aids has become the leading cause of death world-wide. Much research has been done on the causal age...
The main obstacle to cure HIV-1 is the latent reservoir. Antiretroviral therapy effectively controls...
A major barrier to development of a cure for HIV-1 is the ability of the virus to establish latent i...
Highly active antiretroviral therapy (HAART) can reduce plasma HIV-1 levels in infected individuals ...
AbstractReplication-competent latent HIV-1 proviruses that persist in the genomes of a very small su...